Sign In
Pharma
Bharat Biotech's Covaxin booster dose gets nod for trial, to be administered after second shot
Lancet publishes results of Covaxin phase 2 clinical trials
Markets
Reveal vaccine capacities, Delhi HC tells Bharat Biotech
Covaxin's clinical efficacy at 81%
Bizz Talk
We should have waited for the Phase-III trials of Covaxin
Covaxin heads to the US
Bharat Biotech secures a fresh Letter of Comfort from the Centre for 45 lakh doses of Covaxin
COVID-19 vaccine: Bharat Biotech inks purchase order with the government of India
Economy
Bharat Biotech concludes recruitment for Covaxin's Phase-III
69% Indians hesitant to take Covid shot
India's vaccine nationalism is a global risk
Politics
Tharoor criticises govt nod to Covaxin
